Prot #ML40787: A Phase III, Prospective, Double-Blind, Randomized, Placebo-Controlled Trial of Thrombolysis in Imaging-Eligible, Late-Window Patients to Assess the Efficacy and Safety of Tenecteplase (TIMELESS)

Project: Research project

Project Details

StatusActive
Effective start/end date10/17/19 → 10/17/24

Funding

  • DrugDev Inc. (Prot #ML40787)
  • Genentech, Inc. (Prot #ML40787)